Characterization of the Intestinal Microbiome in Patients with and without PSC
Details of Research
Contact: Joanne Stempak, Project Manager
416-586-4800 ext 8399
joanne.stempak@sinaihealth.ca
Primary Investigator: Mark Silverberg, MD
Enrolment: Ongoing
Objective: The objective is to assess the composition of the microbiome in patients with and without PSC, IBD patients without PSC (Ulcerative colitis and colonic Crohn’s disease) and healthy controls.
Expectation: This research may lead to a better understanding of why the disease occurs and what role the gut microbiome and other markers play in PSC and/or IBD.
Eligibility: Anyone who has a confirmed diagnosis of Primary Sclerosing Cholangitis and/or IBD (either Crohn's Disease or Ulcerative Colitis). Also, if you do not have IBD (i.e. Crohn's Disease or Ulcerative colitis) and do not have a family history of IBD and are willing to participate as a healthy control, your help would be greatly appreciated.
Participation Involves:
We would like to sincerely thank all of our study participants. This research couldn't be possible without your cooperation.
Please contact Joanne Stempak (phone 416-586-4800 x8399) if you are interested in participating in this study.